All In Biotech

Drug Trial Radar · NCT06762054

Investigating the Optimal Management of Dolutegravir Resistance

Investigating the Optimal Management of Dolutegravir Resistance: a Multi-country Cohort Study

Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

6,624

Actual

Start

Mar 3, 2025

Primary completion

Feb 15, 2027

Study completion Jan 31, 2028

Sponsor

Lead sponsor
University of NairobiAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Instituto Nacional de Saúde, Mozambique; Muhimbili University of Health and Allied Sciences; SolidarMed; London School of Hygiene and Tropical Medicine
First posted
Jan 7, 2025

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
No
Who can join
All sexes, from 1 year
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study is to address the gap in published data on viral suppression among people meeting the criteria for virologic failure on dolutegravir (DTG)-based ART regimens without a change in regimen. The study will also assess the emergence of DTG-associated drug-resistant mutations and their impact on viral suppression.

Conditions

  • HIV-1-infection

Interventions

  • Continue DTG-based antiretroviral therapyDrug

    Participants will continue on DTG-based ART after enrollment for up to 24 months

  • Enhanced adherence counsellingBehavioral

    Participants with VL ≥200 copies/mL will undergo enhanced adherence counselling

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Viral suppression rateTime frame: 12 months

Locations

9 sites in 4 countries. Site status is shown where the registry gives one.

  • Jaramogi Oginga Odinga Teaching and Referral Hospital

    Kisumu, Kenya

  • Bomu Hospital

    Mombasa, Kenya

  • Kenyatta National Hospital

    Nairobi, Kenya

  • Butha-Buthe District Hospital

    Butha-Buthe, Lesotho

  • Mokhotlong District Hospital

    Mokhotlong, Lesotho

  • CS Machava II

    Maputo, Mozambique

  • CS Ndlavela

    Maputo, Mozambique

  • CS Ponta Gea

    Beira, Sofala, Mozambique

  • MUHAS Clinical Trial Unit

    Dar es Salaam, Tanzania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.